Ionis Pharmaceuticals ROI - Return on Investment 2010-2024 | IONS

Ionis Pharmaceuticals return on investment for the quarter ending September 30, 2024 was -21.91.

  • Ionis Pharmaceuticals average return on investment for 2023 was -20.55, a 425.58% increase from 2022.
  • Ionis Pharmaceuticals average return on investment for 2022 was -3.91, a 83.58% increase from 2021.
  • Ionis Pharmaceuticals average return on investment for 2021 was -23.81, a 1663.7% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Ionis Pharmaceuticals ROI - Return on Investment 2010-2024 | IONS

  • Ionis Pharmaceuticals average return on investment for 2023 was -20.55, a 425.58% increase from 2022.
  • Ionis Pharmaceuticals average return on investment for 2022 was -3.91, a 83.58% increase from 2021.
  • Ionis Pharmaceuticals average return on investment for 2021 was -23.81, a 1663.7% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.